PT Bundamedik Tbk

IDX:BMHS Stock Report

Market Cap: Rp2.3t

Bundamedik Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Agus Darjono

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureno data
Board average tenure2.6yrs

Recent management updates

Recent updates

CEO

Agus Darjono

less than a year

Tenure

Mr. Agus Heru Darjono serves as Director at PT Diagnos Laboratorium Utama Tbk from September 2024. He is President Director of PT Bundamedik Tbk from May 30, 2024. He was President Director of PT Indofarma...

Board Members

NamePositionTenureCompensationOwnership
Agus Darjono
President Directorless than a yearno datano data
Emilia Simatupang
Director of Human Capital & Director2.8yrsno datano data
Sunata Tjiterosampurno
Commissioner2.3yrsno datano data
Mesha Sini
Commissionerless than a yearno data5.65%
IDR 130.4b
Ivan Sini
President Commissioner11.8yrsno data3.24%
IDR 74.7b
Wishnutama Kusubandio
Vice President Commissioner3.8yrsno datano data
Chairul Nasution
Independent Commissioner3.8yrsno datano data
Cuncun Wijaya Wibowo
Director2.3yrsno datano data

2.6yrs

Average Tenure

52yo

Average Age

Experienced Board: BMHS's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.